Usefulness of the GenMark ePlex RPP assay

Usefulness of the GenMark ePlex RPP assay for the detection of respiratory viruses in comparison with the FTD21 multiplex RT-PCR

Cartridge-based multiplex panels overlaying quite a few pathogens provide a bonus of minimal hands-on-time and quick time to consequence to business RT-PCR assays. On this research, we evaluated the efficiency of the ePlex respiratory pathogen panel (RPP) in comparison with the Quick Monitor Diagnostics Respiratory pathogens 21 multiplex RT-PCR assay (FTD21) utilizing 400 medical respiratory samples. Discrepant outcomes had been additional analysed by a reference nucleic acid amplification testing (NAT) and a composite reference method was used for ultimate interpretation. Discordant outcomes had been noticed in 56 targets equivalent to 54 samples. Sensitivities and specificities had been 85.5% and 99.9% for the ePlex RPP and 95.8% and 99.7% for the FTD21 system, respectively. Altogether, the ePlex RPP is a worthwhile device for the speedy detection of quite a lot of completely different respiratory viruses apart from the coronavirus household (low sensitivity starting from 50-80%) and samples with a low pathogen load (Ct values >33).
russelldurrett
russelldurrett

Genorise® Semen DNA Extraction Kit 500

GR101041 500
EUR 480

Genorise® Semen DNA Extraction Kit 200

GR101042 200
EUR 258

Genorise® Semen DNA Extraction Kit 100

GR101043 100
EUR 144

Genorise® Semen DNA Extraction Kit 50

GR101044 50
EUR 87

Genorise® Semen Stain DNA Extraction Kit 1000

GR101017 1000
EUR 1045

Genorise® Semen Stain DNA Extraction Kit 500

GR101069 500
EUR 564

Genorise® Semen Stain DNA Extraction Kit 200

GR101070 200
EUR 243

Genorise® Semen Stain DNA Extraction Kit 100

GR101071 100
EUR 144

Genorise® Semen Stain DNA Extraction Kit 50

GR101072 50
EUR 87

AI-91K LN2 Freezer for Bulk Semen Storage, no controller

TW-AI-91K 1 UNIT
EUR 66671
Description: AI-91K LN2 Freezer for Bulk Semen Storage, no controller

Semenogelin I Protein

20-abx261182
  • EUR 4101.60
  • EUR 393.60
  • EUR 276.00
  • 1 mg
  • 20 ug
  • 5 ug

Semenogelin I antibody

70R-1587 100 ug
EUR 452.4
Description: Rabbit polyclonal Semenogelin I antibody raised against the N terminal of SEMG1

Semenogelin I antibody

70R-1593 100 ug
EUR 452.4
Description: Rabbit polyclonal Semenogelin I antibody raised against the C terminal of SEMG1

Semenogelin I antibody

70R-5491 50 ug
EUR 560.4
Description: Rabbit polyclonal Semenogelin I antibody raised against the middle region of SEMG1

Semenogelin I (SEMG1) Antibody

20-abx115422
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

Semenogelin I (SEMG1) Antibody

20-abx320262
  • EUR 360.00
  • EUR 292.80
  • 100 ul
  • 50 ul

Semenogelin I (SEMG1) Antibody

20-abx322135
  • EUR 360.00
  • EUR 292.80
  • 100 ul
  • 50 ul

Semenogelin I (SEMG1) Antibody

20-abx004204
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Semenogelin I (SEMG1) Antibody

20-abx174508
  • EUR 1028.40
  • EUR 526.80
  • 1 mg
  • 200 ug

Semenogelin I (SEMG1) Antibody

abx237711-100ug 100 ug
EUR 661.2

Semenogelin I (SEMG1) Antibody

20-abx129235
  • EUR 510.00
  • EUR 159.60
  • EUR 1446.00
  • EUR 693.60
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Semenogelin I (SEMG1) Antibody

abx028130-400ul 400 ul
EUR 627.6

Semenogelin I (SEMG1) Antibody

abx028130-80l 80 µl
EUR 343.2

Recombinant Semenogelin I (SEMG1)

4-RPH185Hu01
  • EUR 550.08
  • EUR 271.20
  • EUR 1732.80
  • EUR 657.60
  • EUR 1195.20
  • EUR 444.00
  • EUR 4152.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Semenogelin I expressed in: E.coli

Semenogelin I Blocking Peptide

33R-3239 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SEMG1 antibody, catalog no. 70R-1593

Semenogelin I Blocking Peptide

33R-4289 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SEMG1 antibody, catalog no. 70R-5491

Semenogelin I Blocking Peptide

33R-7601 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SEMG1 antibody, catalog no. 70R-1587

Human Semenogelin I (SEMG1) Protein

20-abx168081
  • EUR 777.60
  • EUR 326.40
  • EUR 2331.60
  • EUR 910.80
  • EUR 560.40
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Human Semenogelin I (SEMG1) CLIA Kit

20-abx495402
  • EUR 9567.60
  • EUR 5095.20
  • EUR 1177.20
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Lung Diabetic Disease Lysate

XBL-10362 0.1 mg
EUR 796.2
Description: Human lung tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human lung tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the lung tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The lung tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Human Semenogelin I (SEMG1) ELISA Kit

20-abx153055
  • EUR 8853.60
  • EUR 4719.60
  • EUR 1093.20
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Human Semenogelin I (SEMG1) ELISA Kit

DLR-SEMG1-Hu-48T 48T
EUR 620.4
Description: A sandwich quantitative ELISA assay kit for detection of Human Semenogelin I (SEMG1) in samples from serum, plasma, seminal plasma or other biological fluids.

Human Semenogelin I (SEMG1) ELISA Kit

DLR-SEMG1-Hu-96T 96T
EUR 807.6
Description: A sandwich quantitative ELISA assay kit for detection of Human Semenogelin I (SEMG1) in samples from serum, plasma, seminal plasma or other biological fluids.

Human Semenogelin I (SEMG1) ELISA Kit

abx250766-96tests 96 tests
EUR 904.8

Human Semenogelin I (SEMG1) ELISA Kit

abx571776-96tests 96 tests
EUR 904.8

Human Semenogelin I(SEMG1)ELISA Kit

QY-E01566 96T
EUR 448.8

Human Semenogelin I (SEMG1) ELISA Kit

RD-SEMG1-Hu-48Tests 48 Tests
EUR 625.2

Human Semenogelin I (SEMG1) ELISA Kit

RD-SEMG1-Hu-96Tests 96 Tests
EUR 867.6

Human Semenogelin I (SEMG1) ELISA Kit

RDR-SEMG1-Hu-48Tests 48 Tests
EUR 652.8

Human Semenogelin I (SEMG1) ELISA Kit

RDR-SEMG1-Hu-96Tests 96 Tests
EUR 907.2

Human Semenogelin I (SEMG1) ELISA Kit

SEH185Hu-10x96wellstestplate 10x96-wells test plate
EUR 5677.8
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Semenogelin I (SEMG1) in serum, plasma, seminal plasma and other biological fluids.

Human Semenogelin I (SEMG1) ELISA Kit

SEH185Hu-1x48wellstestplate 1x48-wells test plate
EUR 572.76
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Semenogelin I (SEMG1) in serum, plasma, seminal plasma and other biological fluids.

Human Semenogelin I (SEMG1) ELISA Kit

SEH185Hu-1x96wellstestplate 1x96-wells test plate
EUR 766.8
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Semenogelin I (SEMG1) in serum, plasma, seminal plasma and other biological fluids.

Human Semenogelin I (SEMG1) ELISA Kit

SEH185Hu-5x96wellstestplate 5x96-wells test plate
EUR 3090.6
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Semenogelin I (SEMG1) in serum, plasma, seminal plasma and other biological fluids.

Human Semenogelin I (SEMG1) ELISA Kit

4-SEH185Hu
  • EUR 5738.40
  • EUR 3031.20
  • EUR 768.00
  • 10 plates of 96 wells
  • 5 plates of 96 wells
  • 1 plate of 96 wells
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Semenogelin I (SEMG1) in samples from serum, plasma, seminal plasma and other biological fluids with no significant corss-reactivity with analogues from other species.

Human Semenogelin I (SEMG1) ELISA Kit

RD-SEMG1-Hu-48T 48T
EUR 452.7
Description: serum, plasma, seminal plasma and other biological fluids.

Human Semenogelin I (SEMG1) ELISA Kit

RD-SEMG1-Hu-96T 96T
EUR 646.7
Description: serum, plasma, seminal plasma and other biological fluids.

Human Semenogelin I (SEMG1) ELISA Kit

RDR-SEMG1-Hu-48T 48T
EUR 475.34
Description: serum, plasma, seminal plasma and other biological fluids.

Human Semenogelin I (SEMG1) ELISA Kit

RDR-SEMG1-Hu-96T 96T
EUR 679.04
Description: serum, plasma, seminal plasma and other biological fluids.

Total RNA - Diabetic Disease: Colon

R1236090Dia-50 50 ug
EUR 421.2

Colon Diabetic Disease Lysate

XBL-10333 0.1 mg
EUR 796.2
Description: Human colon tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human colon tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the colon tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The colon tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Ileum Diabetic Disease Lysate

XBL-10379 0.1 mg
EUR 796.2
Description: Human small intestine: Ileum tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human small intestine: Ileum tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the small intestine: Ileum tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The small intestine: Ileum tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Total RNA - Diabetic Disease: Stomach

R1236248Dia-50 50 ug
EUR 421.2

Jejunum Diabetic Disease Lysate

XBL-10381 0.1 mg
EUR 796.2
Description: Human small intestine: Jejunum tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human small intestine: Jejunum tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the small intestine: Jejunum tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The small intestine: Jejunum tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Stomach Diabetic Disease Lysate

XBL-10387 0.1 mg
EUR 796.2
Description: Human stomach tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human stomach tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the stomach tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The stomach tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Total RNA - Diabetic Disease: Pancreas

R1236188Dia-50 50 ug
EUR 421.2

Duodenum Diabetic Disease Lysate

XBL-10336 0.1 mg
EUR 796.2
Description: Human duodenum tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human duodenum tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the duodenum tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The duodenum tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

ELISA kit for Human SEMG1 (Semenogelin I)

ELK4641 1 plate of 96 wells
EUR 518.4
Description: A sandwich ELISA kit for detection of Semenogelin I from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids.

Total RNA - Diabetic Disease: Esophagus

R1236106Dia-50 50 ug
EUR 421.2

Esophagus Diabetic Disease Lysate

XBL-10338 0.1 mg
EUR 796.2
Description: Human esophagus tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human esophagus tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the esophagus tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The esophagus tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Pancrease Diabetic Disease Lysate

XBL-10371 0.1 mg
EUR 796.2
Description: Human pancrease tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human pancrease tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the pancrease tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The pancrease tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

cDNA - Human Diabetic Diseased Tissue: Lung

C1236152Dia 40 reactions
EUR 729

cDNA - Human Diabetic Diseased Tissue: Skin

C1236218Dia 40 reactions
EUR 729

cDNA - Human Diabetic Diseased Tissue: Brain

C1236035Dia 40 reactions
EUR 729

cDNA - Human Diabetic Diseased Tissue: Colon

C1236090Dia 40 reactions
EUR 729

cDNA - Human Diabetic Diseased Tissue: Heart

C1236122Dia 40 reactions
EUR 729

cDNA - Human Diabetic Diseased Tissue: Liver

C1236149Dia 40 reactions
EUR 729

SEMG1 Semenogelin I Human Recombinant Protein

PROTP04279 Regular: 20ug
EUR 380.4
Description: SEMG1 Human Recombinant produced in E. coli is a single polypeptide chain containing 462 amino acids (24-462) and having a molecular mass of 52kDa. SEMG1 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Semenogelin I (SEMG1) Polyclonal Antibody (Human)

4-PAH185Hu01
  • EUR 296.40
  • EUR 3012.00
  • EUR 750.00
  • EUR 372.00
  • EUR 256.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Semenogelin I (SEMG1)

cDNA - Human Diabetic Diseased Tissue: Whole Eye

C1236108Dia-10 10 reactions
EUR 393

cDNA - Human Diabetic Diseased Tissue: Kidney

C1236142Dia 40 reactions
EUR 729

cDNA - Human Diabetic Diseased Tissue: Spleen

C1236246Dia 40 reactions
EUR 729

Skeletal Muscle Diabetic Disease Lysate

XBL-10369 0.1 mg
EUR 796.2
Description: human skeletal muscle tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human skeletal muscle tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the Skeletal Muscle tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The Skeletal Muscle tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Collagen Type I (Collagen Type I) Antibody

abx231836-100ug 100 ug
EUR 610.8

Collagen Type I (Collagen Type I) Antibody

abx022733-05ml 0.5 ml
EUR 1713.6

Collagen Type I (Collagen Type I) Antibody

abx022734-02mg 0.2 mg
EUR 1312.8

Collagen Type I (Collagen Type I) Antibody

abx022736-05ml 0.5 ml
EUR 1696.8

Collagen Type I (Collagen Type I) Antibody

abx022737-05ml 0.5 ml
EUR 1412.4

Collagen Type I (Collagen Type I) Antibody

abx020882-100ug 100 ug
EUR 1161.6

Collagen Type I (Collagen Type I) Antibody

20-abx101265
  • EUR 477.60
  • EUR 159.60
  • EUR 1328.40
  • EUR 644.40
  • EUR 376.80
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Collagen Type I (Collagen Type I) Antibody

20-abx101266
  • EUR 510.00
  • EUR 159.60
  • EUR 1412.40
  • EUR 693.60
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Collagen Type I (Collagen Type I) Antibody

20-abx130515
  • EUR 493.20
  • EUR 159.60
  • EUR 1362.00
  • EUR 661.20
  • EUR 376.80
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

cDNA - Human Diabetic Diseased Tissue: Lymph Node

C1236161Dia-10 10 reactions
EUR 393

cDNA - Human Diabetic Diseased Tissue: Stomach

C1236248Dia 40 reactions
EUR 729

cDNA - Human Diabetic Diseased Tissue: Bone Marrow

C1236024Dia-10 10 reactions
EUR 420

cDNA - Human Diabetic Diseased Tissue: Pancreas

C1236188Dia 40 reactions
EUR 729

Pancreas Membrane Diabetic Disease Lysate

XBL-10785 0.1 mg
EUR 752.1
Description: Human pancreas tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human pancreas tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated pancreas tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated pancreas tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal.

Semenogelin I (SEMG1) Polyclonal Antibody (Human), PE

4-PAH185Hu01-PE
  • EUR 355.20
  • EUR 3168.00
  • EUR 900.00
  • EUR 446.40
  • EUR 234.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Semenogelin I (SEMG1). This antibody is labeled with PE.

cDNA - Human Diabetic Diseased Tissue: Esophagus

C1236106Dia 40 reactions
EUR 729

Membrane Protein - Diabetic Disease: Pancreas

P3236188Dia 0.1 mg
EUR 410

Semenogelin I (SEMG1) Polyclonal Antibody (Human), APC

4-PAH185Hu01-APC
  • EUR 414.00
  • EUR 3930.00
  • EUR 1094.40
  • EUR 528.00
  • EUR 262.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Semenogelin I (SEMG1). This antibody is labeled with APC.

Semenogelin I (SEMG1) Polyclonal Antibody (Human), Cy3

4-PAH185Hu01-Cy3
  • EUR 502.80
  • EUR 5190.00
  • EUR 1410.00
  • EUR 654.00
  • EUR 301.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Semenogelin I (SEMG1). This antibody is labeled with Cy3.

Semenogelin I (SEMG1) Polyclonal Antibody (Human), HRP

4-PAH185Hu01-HRP
  • EUR 379.20
  • EUR 3426.00
  • EUR 968.40
  • EUR 477.60
  • EUR 247.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Semenogelin I (SEMG1). This antibody is labeled with HRP.

Total Protein - Human Diabetic Diseased Tissue: Lung

P1236152Dia 1 mg
EUR 471

Total Protein - Human Diabetic Diseased Tissue: Skin

P1236218Dia 1 mg
EUR 471

Semenogelin I (SEMG1) Polyclonal Antibody (Human), FITC

4-PAH185Hu01-FITC
  • EUR 355.20
  • EUR 3168.00
  • EUR 900.00
  • EUR 446.40
  • EUR 234.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Semenogelin I (SEMG1). This antibody is labeled with FITC.

Adipose Subcutaneous Diabetic Disease Lysate

20-105 0.1 mg
EUR 1508.1
Description: Human subcutaneous adipose tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human subcutaneous adipose tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the subcutaneous adipose tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The subcutaneous adipose tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Total Protein - Human Diabetic Diseased Tissue: Brain

P1236035Dia 1 mg
EUR 471

Total Protein - Human Diabetic Diseased Tissue: Colon

P1236090Dia 1 mg
EUR 471

Total Protein - Human Diabetic Diseased Tissue: Heart

P1236122Dia 1 mg
EUR 471

Total Protein - Human Diabetic Diseased Tissue: Liver

P1236149Dia 1 mg
EUR 471

cDNA - Human Diabetic Diseased Tissue: Skeletal Muscle

C1236171Dia 40 reactions
EUR 729

Total Protein - Human Diabetic Diseased Tissue: Whole Eye

P1236108Dia 1 mg
EUR 1147

Total Protein - Human Diabetic Diseased Tissue: Kidney

P1236142Dia 1 mg
EUR 471

Total Protein - Human Diabetic Diseased Tissue: Spleen

P1236246Dia 1 mg
EUR 471

Skeletal Muscle Membrane Diabetic Disease Lysate

XBL-10855 0.1 mg
EUR 752.1
Description: human skeletal muscle tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human skeletal muscle tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated Skeletal Muscle tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated Skeletal Muscle tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal.

cDNA - Human Diabetic Diseased Tissue: Visceral Adipose

C1236003VisDia-10 10 reactions
EUR 420

Total Protein - Human Diabetic Diseased Tissue: Adrenal

P1236004Dia 1 mg
EUR 471

Total Protein - Human Diabetic Diseased Tissue: Stomach

P1236248Dia 1 mg
EUR 471

Membrane Protein - Diabetic Disease: Skeletal Muscle

P3236171Dia 0.1 mg
EUR 410

Total Protein - Human Diabetic Diseased Tissue: Bone Marrow

P1236024Dia 1 mg
EUR 1147

Total Protein - Human Diabetic Diseased Tissue: Pancreas

P1236188Dia 1 mg
EUR 471

Frozen Tissue Section - Human Diabetic Diseased Tissue: Eye

T1236108Dia 5 slides
EUR 662

cDNA - Human Diabetic Diseased Tissue: Small Intestine: Ileum

C1236227Dia 40 reactions
EUR 729

Total Protein - Human Diabetic Diseased Tissue: Esophagus

P1236106Dia 1 mg
EUR 471

Frozen Tissue Section - Human Diabetic Diseased Tissue: Lung

T1236152Dia 5 slides
EUR 475

Frozen Tissue Section - Human Diabetic Diseased Tissue: Skin

T1236218Dia 5 slides
EUR 475

Semenogelin I (SEMG1) Polyclonal Antibody (Human), APC-Cy7

4-PAH185Hu01-APC-Cy7
  • EUR 685.20
  • EUR 7716.00
  • EUR 2046.00
  • EUR 912.00
  • EUR 382.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Semenogelin I (SEMG1). This antibody is labeled with APC-Cy7.

Frozen Tissue Section - Human Diabetic Diseased Tissue: Brain

T1236035Dia 5 slides
EUR 475

Frozen Tissue Section - Human Diabetic Diseased Tissue: Colon

T1236090Dia 5 slides
EUR 475

Frozen Tissue Section - Human Diabetic Diseased Tissue: Heart

T1236122Dia 5 slides
EUR 475

Frozen Tissue Section - Human Diabetic Diseased Tissue: Liver

T1236149Dia 5 slides
EUR 475

Semenogelin I (SEMG1) Polyclonal Antibody (Human), Biotinylated

4-PAH185Hu01-Biotin
  • EUR 373.20
  • EUR 2952.00
  • EUR 872.40
  • EUR 457.20
  • EUR 262.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Semenogelin I (SEMG1). This antibody is labeled with Biotin.

cDNA - Human Diabetic Diseased Tissue: Subcutaneous Adipose

C1236003SubDia-10 10 reactions
EUR 420

cDNA - Human Diabetic Diseased Tissue: Small Intestine: Jejunum

C1236230Dia 40 reactions
EUR 729

Genomic DNA - Human Diabetic Diseased Tissue: Lung, from a single donor

D1236152Dia 50 ug
EUR 489

Genomic DNA - Human Diabetic Diseased Tissue: Skin, from a single donor

D1236218Dia 50 ug
EUR 489

Frozen Tissue Section - Human Diabetic Diseased Tissue: Kidney

T1236142Dia 5 slides
EUR 475

Frozen Tissue Section - Human Diabetic Diseased Tissue: Spleen

T1236246Dia 5 slides
EUR 475

Paraffin Tissue Section - Human Diabetic Diseased Tissue: Lung

T2236152Dia 5 slides
EUR 238

cDNA - Human Diabetic Diseased Tissue: Small Intestine: Duodenum

C1236101Dia 40 reactions
EUR 729

Genomic DNA - Human Diabetic Diseased Tissue: Brain, from a single donor

D1236035Dia 50 ug
EUR 489

Genomic DNA - Human Diabetic Diseased Tissue: Colon, from a single donor

D1236090Dia 50 ug
EUR 489

Genomic DNA - Human Diabetic Diseased Tissue: Heart, from a single donor

D1236122Dia 50 ug
EUR 489

Genomic DNA - Human Diabetic Diseased Tissue: Liver, from a single donor

D1236149Dia 50 ug
EUR 489

Total Protein - Human Diabetic Diseased Tissue: Skeletal Muscle

P1236171Dia 1 mg
EUR 471

Frozen Tissue Section - Human Diabetic Diseased Tissue: Adrenal

T1236004Dia 5 slides
EUR 475

Frozen Tissue Section - Human Diabetic Diseased Tissue: Stomach

T1236248Dia 5 slides
EUR 475

Paraffin Tissue Section - Human Diabetic Diseased Tissue: Colon

T2236090Dia 5 slides
EUR 238

Paraffin Tissue Section - Human Diabetic Diseased Tissue: Liver

T2236149Dia 5 slides
EUR 238

Genomic DNA - Human Diabetic Diseased Tissue: Whole Eye, from a single donor

D1236108Dia 50 ug
EUR 1152

Genomic DNA - Human Diabetic Diseased Tissue: Kidney, from a single donor

D1236142Dia 50 ug
EUR 489

Genomic DNA - Human Diabetic Diseased Tissue: Spleen, from a single donor

D1236246Dia 50 ug
EUR 489

Total Protein - Human Diabetic Diseased Tissue: Visceral Adipose

P1236003VisDia 1 mg
EUR 1147

Frozen Tissue Section - Human Diabetic Diseased Tissue: Bone Marrow

T1236024Dia 5 slides
EUR 662

Frozen Tissue Section - Human Diabetic Diseased Tissue: Pancreas

T1236188Dia 5 slides
EUR 475

Genomic DNA - Human Diabetic Diseased Tissue: Adrenal, from a single donor

D1236004Dia 50 ug
EUR 489

Genomic DNA - Human Diabetic Diseased Tissue: Stomach, from a single donor

D1236248Dia 50 ug
EUR 489

Frozen Tissue Section - Human Diabetic Diseased Tissue: Esophagus

T1236106Dia 5 slides
EUR 475

Paraffin Tissue Section - Human Diabetic Diseased Tissue: Stomach

T2236248Dia 5 slides
EUR 238

Genomic DNA - Human Diabetic Diseased Tissue: Bone Marrow, from a single donor

D1236024Dia 50 ug
EUR 1152

Genomic DNA - Human Diabetic Diseased Tissue: Esophagus, from a single donor

D1236106Dia 50 ug
EUR 489

Genomic DNA - Human Diabetic Diseased Tissue: Pancreas, from a single donor

D1236188Dia 50 ug
EUR 489

Total Protein - Human Diabetic Diseased Tissue: Small Intestine: Ileum

P1236227Dia 1 mg
EUR 471

Paraffin Tissue Section - Human Diabetic Diseased Tissue: Bone Marrow

T2236024Dia 5 slides
EUR 238

Paraffin Tissue Section - Human Diabetic Diseased Tissue: Esophagus

T2236106Dia 5 slides
EUR 238

Paraffin Tissue Section - Human Diabetic Diseased Tissue: Pancreas

T2236188Dia 5 slides
EUR 238

Total Protein - Human Diabetic Diseased Tissue: Subcutaneous Adipose

P1236003SubDia 1 mg
EUR 1147

Total Protein - Human Diabetic Diseased Tissue: Small Intestine: Duodenum

P1236101Dia 1 mg
EUR 471

Total Protein - Human Diabetic Diseased Tissue: Small Intestine: Jejunum

P1236230Dia 1 mg
EUR 471

Frozen Tissue Section - Human Diabetic Diseased Tissue: Visceral Adipose

T1236003VisDia 5 slides
EUR 662

Frozen Tissue Section - Human Diabetic Diseased Tissue: Skeletal Muscle

T1236171Dia 5 slides
EUR 475

Paraffin Tissue Section - Human Diabetic Diseased Tissue: Parathyroid

T2236189Dia 5 slides
EUR 629

Genomic DNA - Human Diabetic Diseased Tissue: Visceral Adipose, from a single donor

D1236003VisDia 50 ug
EUR 1152

Genomic DNA - Human Diabetic Diseased Tissue: Skeletal Muscle, from a single donor

D1236171Dia 50 ug
EUR 489

Frozen Tissue Section - Human Diabetic Diseased Tissue: Small Intestine: Ileum

T1236227Dia 5 slides
EUR 475

Paraffin Tissue Section - Human Diabetic Diseased Tissue: Skeletal Muscle

T2236171Dia 5 slides
EUR 238

Genomic DNA - Human Diabetic Diseased Tissue: Small Intestine: Ileum, from a single donor

D1236227Dia 50 ug
EUR 489

Frozen Tissue Section - Human Diabetic Diseased Tissue: Subcutaneous Adipose

T1236003SubDia 5 slides
EUR 662

Frozen Tissue Section - Human Diabetic Diseased Tissue: Small Intestine: Jejunum

T1236230Dia 5 slides
EUR 475

Paraffin Tissue Section - Human Diabetic Diseased Tissue: Small Intestine: Ileum

T2236227Dia 5 slides
EUR 238

Genomic DNA - Human Diabetic Diseased Tissue: Subcutaneous Adipose, from a single donor

D1236003SubDia 50 ug
EUR 1152

Genomic DNA - Human Diabetic Diseased Tissue: Small Intestine: Jejunum, from a single donor

D1236230Dia 50 ug
EUR 489

Frozen Tissue Section - Human Diabetic Diseased Tissue: Small Intestine: Duodenum

T1236101Dia 5 slides
EUR 475

Paraffin Tissue Section - Human Diabetic Diseased Tissue: Small Intestine: Jejunum

T2236230Dia 5 slides
EUR 238

Procollagen Type I (212-216)

H-1592.0005 5.0mg
EUR 151.2
Description: Sum Formula: C23H45N7O9; CAS# [149128-48-3]

Procollagen Type I (212-216)

H-1592.0025 25.0mg
EUR 501.6
Description: Sum Formula: C23H45N7O9; CAS# [149128-48-3]

Collagen Type I protein

30R-AC016 500 ug
EUR 528
Description: Purified native Human Collagen Type I Solution

Collagen Type I protein

E62L001 1mg
EUR 1425.6

Genomic DNA - Human Diabetic Diseased Tissue: Small Intestine: Duodenum, from a single donor

D1236101Dia 50 ug
EUR 489

Paraffin Tissue Section - Human Diabetic Diseased Tissue: Small Intestine: Duodenum

T2236101Dia 5 slides
EUR 238

Collagen Type I antibody

10-1800 200 ul
EUR 846
Description: Mouse monoclonal Collagen Type I antibody

Collagen Type I antibody

10R-C139b 100 ug
EUR 976.8
Description: Mouse monoclonal Collagen Type I antibody

Collagen Type I antibody

70R-CR007x 100 µg
EUR 379.2
Description: Affinity purified Rabbit polyclonal Collagen Type I antibody

Collagen Type I antibody

20R-CR025 500 ul
EUR 950.4
Description: Rabbit polyclonal Collagen Type I antibody

Collagen Type I antibody

PAab09910 100 ug
EUR 463.2

Procollagen Type I protein

E62L008 100ug
EUR 1035.6

Type I Safety Can 4L

SAF7976 EACH
EUR 143.62

Mixture of a SARS-CoV-2 IgG Assay and RT-PCR for Improved COVID-19 Analysis

Background: Coronavirus illness 2019 (COVID-19), brought on by extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is mostly recognized by reverse transcription (RT)-PCR or serological assays. The SARS-CoV-2 viral load decreases just a few days after symptom onset. Thus, the RT-PCR sensitivity peaks at three days after symptom onset (roughly 80%). We evaluated the efficiency of the ARCHITECT® SARS-CoV-2 IgG assay (henceforth termed IgG assay; Abbott Laboratories, Lake County, IL, USA), and the mixture of RT-PCR and the IgG assay for COVID-19 analysis.
Strategies: On this retrospective research, 206 samples from 70 COVID-19 instances at two hospitals in Tokyo that had been constructive utilizing RT-PCR had been used to investigate the diagnostic sensitivity. RT-PCR-negative (N=166), COVID-19-unrelated (N=418), and Japanese Pink Cross Society (N=100) samples had been used to guage specificity.
Outcomes: Sensitivity elevated day by day after symptom onset and exceeded 84.4% after 10 days. Specificity ranged from 98.2% to 100% for samples from the three case teams. Seroconversion was confirmed from 9 to 20 days after symptom onset in 18 out of 32 COVID-19 instances with a number of samples and from one other case with a constructive consequence within the IgG assay for the primary accessible pattern.
Conclusions: The mix of RT-PCR and IgG assay improves the robustness of laboratory diagnostics by compensating for the constraints of every technique.

Simultaneous Molecular Detection of Frequent Bacterial Enteropathogens in Youngsters with Diarrhea by Multiplex-PCR Assay

Background: Diarrhea stays a serious risk to kids in low- and middle-income international locations, which is the second explanation for dying amongst kids on the planet. The intention of the current research was to develop and consider a multiplex-PCR assay for direct detection of widespread bacterial enteropathogens in fecal specimens.
Strategies: 100 and three stool specimens had been collected from kids beneath 5 years of age with gastroenteritis throughout a six-month interval in Ilam, Iran. The multiplex PCR assay concurrently detected Shigella spp., Campylobacter jejuni, Enteropathogenic Escherichia coli (EPEC), Enterotoxigenic Escherichia coli (ETEC), and Salmonella enterica in stool samples.
Outcomes: Our outcomes demonstrated that the prevalence of Shigella spp. Campylobacter jejuni, EPEC, ETEC, and Salmonella enterica had been 21.35%, 10.67%, 1.94%, 0.97% and 0%, respectively. As well as, Shigella spp. with Campylobacter jejuni and EPEC with Campylobacter jejuni coinfection had been noticed in pattern 11 (10.67%). The analytical sensitivity of the multiplex PCR assay was estimated to be 0.01 ng/µL of genomic DNA from tradition. The analytical specificity was decided to be 100% through the use of widespread and customary enteropathogenic bacterial strains.
Conclusions: The molecular technique developed within the research was speedy, delicate, and particular for detection of widespread bacterial enteropathogens.

Screening of ZIKA virus an infection amongst dengue-like sickness sufferers with damaging RT-PCR for dengue virus in Punjab – Pakistan

Goal: To detect ZIKV utilizing reverse transcription-polymerase chain response (RT-PCR) amongst medical samples examined damaging for Dengue virus (DENV) by RT-PCR in Punjab, 2016.
Strategies: A descriptive cross-sectional research was carried out for length of two months. Whole of 506 samples had been collected inside seven days from onset of sickness from throughout hospitals of Punjab, Pakistan of which 350 had been chosen merely randomly to check for presence of ZIKV through the use of “Trioplex Actual-Time RT-PCR Assay (Trioplex)”. Cohen’s kappa coefficient (κ) and 95% confidence interval (CI) had been used to evaluate the diploma of concordance between DENV constructive outcomes of non-structural protein 1 (NS1) and IgM solid-phase enzyme immunoassay (ELISA).
Outcomes: No samples had been constructive for any ZIKV, DENV or Chikungunya virus (CHIKV) by Trioplex. Among the many 350 samples, 26 samples had been constructive concordant and the diploma of concordance between NS1- and IgM-ELISA was 13% and κ coefficient was -0.71 (95% CI -0.79, -0.63).
Conclusion: At research time, no samples had been constructive for ZIKV. Strengthening laboratory capability to verify arboviruses for Punjab’s laboratories is warranted. Trioplex RT-PCR has 100% sensitivity so there are nominal probabilities of false damaging outcomes. Establishing syndromic surveillance for Zika and conducting a sero-surveillance survey for Zika in areas with excessive human and Aedes mosquito density are advisable in Punjab.

Repositive RT-PCR take a look at in discharged COVID-19 sufferers throughout medical isolation commentary

Targets: The epidemiological and medical traits of sufferers with coronavirus illness 2019 (COVID-19) have been researched. Nonetheless, the prevalence of repositivity by real-time PCR for extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2) stays unclear.
Strategies: A retrospective research was carried out involving 599 discharged sufferers with COVID-19 in a single medical centre. The medical options of sufferers throughout their hospitalization and 14-day post-discharge quarantine had been collected.
Outcomes: A complete of 122 sufferers (20.4%) out of 599 sufferers retested constructive after discharge. Particularly, 94 (15.7%) retested constructive inside 24 h of discharge, and one other 28 sufferers (4.7%) had been repositive on day 7 after discharge, though none confirmed any medical symptomatic recurrence. Each repositives and non‑repositives have related patterns of IgG and IgM. Notably, the size of hospitalization of non-repositive sufferers was longer than that of 24-h repositive sufferers and 7-day repositive sufferers. As well as, the size of hospitalization of 24-h repositive sufferers was shorter than that of 7-day repositive sufferers, indicating that the size of hospitalization was additionally a determinant of viral shedding.
Conclusion: Our research supplies additional info for bettering the administration of recovered and discharged sufferers, and additional research must be carried out to elucidate the infectiveness of people with extended or RNA repositivity.

Leave a Reply

Your email address will not be published. Required fields are marked *